ArticleOncotarget2016

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.

Caroline Jochems et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.